…, 7 days in healthcare (November 16th-22nd, 2026)

Summary
News of the week:
- Proposals by Alan Milburn in the United Kingdom to provide employment for one million young people aged 21–24 who are neither working nor studying.
The most significant healthcare-related news stories of the week were:
- Biomedicine: Globally, 47% of clinical care activities could be replaced by AI.
- Global health: The world is subject to extreme tensions between nuclear powers, which could trigger a nuclear war.
- International health policy: 39 million deaths projected by 2050 due to antibiotic resistance.
- National health policy: The government has approved the Statute for the State Public Health Agency.
- Corporate: HM Hospitales and the Torrelodones City Council are promoting a public-private partnership model focused on disease prevention.
Biomedicine
- Which medical specialties are most susceptible to being replaced by AI? Anatomic pathology is, in fact, the only specialty where 100% of the work could be replaced by AI. Other specialties with high potential for replacement include diagnostic radiology (96%), cardiology (80%), radiation oncology (66%), internal medicine (64%), emergency medicine (64%), family medicine (59%), interventional cardiology (57%), and hematology/oncology (54%). Further down the list are urology (30%), ophthalmology (22%), orthopedic surgery (15%), nephrology (13%), and dermatology (9%). Overall, the study asserts that 47% of the clinical care activities analyzed could potentially be replaced by artificial intelligence.
- At least 10% of the population experiences problematic internet use. The journal *The Lancet* urges governments to take action to combat issues such as online gambling and gaming disorders, addictive consumption of pornography, and health anxiety (hypochondria) fueled by the internet.
- A new drug for pancreatic cancer has halted tumor growth in 90% of patients. These are promising, though still small-scale, clinical trials.
Global Health
- What are we doing about the threat of nuclear war? The world is under extreme tension, with several nuclear-armed powers—including Russia, the U.S., and Israel—involved. There are over 12,000 nuclear warheads globally. Given the vast number of urban centers, one might assume the world could survive a nuclear war; however, that is not necessarily the case.
- It is not just in the U.S.: measles cases are rising worldwide. Due to eroding trust in vaccines and reduced funding, we are seeing setbacks in the fight against a disease that is easily preventable.
- Antimicrobial resistance: The WHO notes some progress but calls for redoubled efforts. By 2050, as many as 39 million deaths could be attributed to antibiotic resistance.
International Health Policy
- Alan Milburn’s review on young people and employment: key takeaways. The 276-page report aims to prevent labor market inactivity among 21- to 24-year-olds. It proposes welfare measures, support systems for young people, incentives for businesses that hire them, and educational initiatives—while also outlining projected costs and potential savings.
- The U.S. must ramp up vaccination efforts to regain its status as a measles-free nation, a goal it had achieved 26 years ago.
- Lula’s new administration: a focus on defending science, public health, and the Amazon. Although the re-elected president campaigned on these commitments, he faces a hostile National Congress. National Health Policy (Spain)
- The Government has approved the Statute for the State Public Health Agency. This body, which will operate under the Ministry of Health, will possess its own legal status and the autonomy to manage health emergencies.
- The government is increasing the ISFAS (Armed Forces Social Institute) healthcare contract by 8.2% to prevent the tender from failing due to a lack of bidders once again. The Council of Ministers has given the green light to inject 50 million euros into the tender.
Companies
- International
o Lilly has set a record with deals totaling 51 billion euros since January. The pharmaceutical company—owner of Mounjaro and Zepbound—has announced 16 agreements since the beginning of the year, including acquisitions and strategic alliances, aimed at diversifying its portfolio.
- Domestic
o HM Hospitales and the Torrelodones City Council are promoting a public-private cooperation model focused on the proactive management of disease. The agreement establishes a framework for such cooperation between local government and the private healthcare sector, combining knowledge of the local area with proximity to the public.
Biomedicine
- Multiple sclerosis: going beyond the control of relapses. Affecting 3 million people, this condition has seen some of the most striking changes in both diagnosis and treatment among all neurological diseases (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02345-7/fulltext)
- Defining success in kidney xenotransplantation. It could serve as a bridge while awaiting a human organ transplant—thereby avoiding the need for dialysis—or as a definitive, long-term solution. In the former case, however, it may not be a viable option, given the high cost of the required medication (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01999-9/fulltext)
- What can genes reveal about chronic pain? The largest clinical trial to date identifies new biological roots in the brain (https://www.nytimes.com/2026/11/17/science/genes-chronic-pain.html). Access the original paper in *Nature*: https://www.nature.com/articles/s41593-026-02455-1
- Six-year-olds: the new frontier for Novo’s weight-loss drugs. New clinical trials are now underway for children of this age (https://www.ft.com/content/d08ee4e3-210d-45d2-92be-2b98a8b150b6?syn-25a6b1a6=1)
- A new drug for pancreatic cancer halts tumor growth in 90% of patients. Promising, albeit small-scale, trials (https://www.ft.com/content/6f8575e7-48df-4537-8c8d-73433f086e87?syn-25a6b1a6=1)
- Merck announces that a new drug extends survival in trials for stomach and esophageal cancer (https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-drug-prolongs-survival-advanced-stomach-esophageal-cancers-trial-2026-11-20/)
- How virtual cells could transform medicine: AI-powered cellular models may aid in the development of new drugs and anti-aging therapies (https://www.nytimes.com/2026/11/18/science/ai-virtual-human-cells.html)
- Brain implants enable patients with ALS to speak and sing (https://www.nytimes.com/2026/11/14/science/brain-implants-als-voice.html)
- At least 10% of the population experiences problematic internet use. The journal *The Lancet* urges governments to take action against issues such as online gambling and gaming disorders, addictive pornography consumption, and internet-induced hypochondria (https://elpais.com/salud-y-bienestar/2026-11-19/al-menos-el-10-de-la-poblacion-mundial-sufre-un-uso-problematico-del-internet-hay-que-priorizar-la-salud-publica-frente-a-la-industria.html). Access to the original work in *The Lancet*: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(26)00243-9/abstract
- Which medical specialties are the easiest to replace with AI? Anatomic pathology is, in fact, the only specialty whose activities could be 100% replaced by AI. It is followed—with more than half of their activities potentially replaceable—by diagnostic radiology (96%), cardiology (80%), radiation oncology (66%), internal medicine (64%), emergency medicine (64%), family medicine (59%), interventional cardiology (57%), and hematology/oncology (54%). Further down the list are urology (30%), ophthalmology (22%), orthopedic surgery (15%), nephrology (13%), and dermatology (9%). Taking all of these into account, the study asserts that 47% of the clinical activity analyzed could potentially be replaced by artificial intelligence (https://www.consalud.es/profesionales/medicina/que-especialidades-medicas-estan-mas-cerca-de-ser-reemplazas-por-la-ia.html). Access to the original document from *NEJM AI*: https://ai.nejm.org/doi/full/10.1056/AIp2600957
Global Health
- A manifesto to protect public health. At the European Public Health Conference held in Bilbao, Martin McKee argued that public health will only survive if its knowledge, ethics, and networks remain outside of state control (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02336-6/fulltext)
- It’s not just in the U.S.: measles is on the rise worldwide. Due to the erosion of trust in vaccines and reduced funding, we are seeing setbacks regarding a disease that is easily preventable (https://www.science.org/content/article/it-s-not-just-u-s-measles-roaring-back-around-globe)
- How measles is spreading across the globe: the same points mentioned above, as explained by the Financial Times (https://www.ft.com/content/a71192b7-708c-4bd4-abb6-31c82113794a?syn-25a6b1a6=1)
- What are we doing about the threat of nuclear war? The world is under extreme tension, with many of these pressures involving nuclear-armed powers: Russia, the U.S., and Israel. There are over 12,000 nuclear warheads in existence. Given the vast number of urban centers, one might assume the world could survive a nuclear war—but that is not necessarily the case (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02246-4/fulltext)
- Bacterial resistance to medication: Bacterial resistance to medicines: the WHO notes progress but calls for redoubled efforts. 39 million deaths could be attributed to antibiotic resistance by 2050 (https://www.lemonde.fr/sante/article/2026/11/16/resistance-des-bacteries-aux-medicaments-l-oms-note-des-progres-mais-appelle-a-redoubler-d-efforts_6811683_1651302.html)
- In the DRC, Ebola is killing children on a massive scale (https://www.lemonde.fr/afrique/article/2026/11/18/en-rdc-ebola-tue-massivement-les-enfants-je-ne-peux-meme-pas-le-prendre-dans-mes-bras-pour-le-reconforter_6813071_3212.html)
- Antibiotics: prescriptions are decreasing, notably among children, but the risks remain (https://www.lemonde.fr/sante/article/2026/11/17/antibiotiques-les-prescriptions-et-la-consommation-diminuent-notamment-chez-les-enfants-mais-les-risques-de-l-antibioresistance-demeurent_6812891_1651302.html)
International Health Policy
• USA
o The return of measles to the USA. Reversing this absurd situation could be slow and costly (https://www.economist.com/united-states/2026/11/18/the-return-of-measles-in-america)
o The USA has drastically cut funding for biomedical science abroad. Oversight of grants has been weakened (https://www.economist.com/science-and-technology/2026/11/18/america-has-slashed-funding-for-biomedical-science-abroad)
o The USA must ramp up vaccination efforts to regain its measles-free status, following a 26-year period without the disease (https://www.reuters.com/world/us-loses-measles-free-status-after-26-year-run-source-says-2026-11-16/)
o The USA is providing $47 million to 15 organizations to test chronic disease prevention (https://www.reuters.com/legal/litigation/us-awards-47-million-15-organizations-test-chronic-disease-prevention-medicare-2026-11-20/)
o HIV research may once again receive federal funding (https://www.nytimes.com/2026/11/20/science/hiv-research-funding-nih.html)
o Democrats blame RFK Jr. for the measles situation. The WHO states that measles is endemic in the U.S. for the first time in 26 years (https://www.politico.com/news/2026/11/17/us-loses-measles-elimination-status-democrats-ponder-oversight-01169609)
o U.S. global health aid is not dead; it is evolving. Countries seeking such aid are now required to negotiate “America First” terms with the U.S. (https://www.nytimes.com/2026/11/16/world/american-global-health-aid-isnt-dead-its-changing.html)
• China
o A 15-year funding initiative aimed at attracting the brightest young scientists from across the globe. The Asian giant is already responsible for 31% of the world’s scientific publications (https://www.elmundo.es/salud/2026/11/20/6afaec7b21efa05a3e8b458b.html)
• United Kingdom
o Alan Milburn’s review on young people and employment: key takeaways. The 276-page report seeks to prevent labor inactivity among 21- to 24-year-olds. It proposes welfare measures, support for young people, incentives for businesses that hire them, and educational initiatives, while also outlining projected costs and potential savings (https://www.ft.com/content/3d1308a7-e10b-462a-aaca-5378d79d14f5?syn-25a6b1a6=1). Access to the original Milburn document: https://assets.publishing.service.gov.uk/media/6afb1fc5ccb3ea58ac8743c1/from-a-welfare-state-to-a-working-state-full-report.pdf
o Understanding the implications of the Milburn document for future generations. Nearly a million young people aged 21 to 24 are not in any form of employment or training, and many are inactive due to illness or disability (https://www.kingsfund.org.uk/insight-and-analysis/blogs/milburn-review-neet-crisis-young-people-health)
o Palantir’s contract with the NHS will come to an end, but not before 2029 (https://www.bmj.com/content/395/bmj-2026-101495)
• France
o The “how-to” guide for assisted dying, published by the French National Authority for Health (Haute Autorité de Santé). It defines the medical protocols for implementing “assisted dying” (https://www.lemonde.fr/societe/article/2026/11/19/la-haute-autorite-de-sante-publie-le-mode-d-emploi-de-l-aide-a-mourir_6813279_3224.html)
o Avian influenza: France raises risk level to its highest point (https://www.lemonde.fr/planete/article/2026/11/19/grippe-aviaire-la-france-releve-le-risque-a-son-niveau-le-plus-eleve_6813274_3244.html)
• Brazil
o Lula’s new legislative term: a focus on defending science, healthcare, and the Amazon. Although the re-elected president had committed to these principles, he faces a hostile National Congress (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02234-8/fulltext)
• Chile
o Crisis in hospital emergency departments in the Metropolitan Region. Patients in life-threatening conditions waited up to 73 hours (https://www.emol.com/noticias/Nacional/2026/09/14/1211402/contraloria-y-espera-urgencias.html?utm_source=chatgpt.com)
• Mexico
o The president acknowledges that the healthcare backlog will not be resolved quickly. When asked about Andrés Manuel López Obrador’s claim that Mexico already had a healthcare system comparable to Denmark’s, President Claudia Sheinbaum acknowledged that more hospital beds are still needed and that the backlog accumulated over 36 years cannot be resolved in one or two years. (https://www.reforma.com/admite-csp-que-rezago-en-salud-no-se-resuelve-rapido/ar3278261?utm_source=chatgpt.com)
• Peru
o The El Niño phenomenon threatens 4,393 healthcare facilities due to rains and flooding (https://elcomercio.pe/peru/el-nino-amenaza-la-primera-linea-de-salud-4393-establecimientos-estan-en-riesgo-ante-lluvias-e-inundaciones-apuesplan-noticia/?utm_source=chatgpt.com#google_vignette)
- European Union
o Resistant infections are resurging in European hospitals. Strains of *Klebsiella pneumoniae* are resistant even to the newest antibiotics (https://www.politico.eu/article/drug-resistant-infections-superbug-europe-hospitals/)
o Pancreatic cancer: European Commission gives the green light to a new treatment (https://www.lemonde.fr/economie/article/2026/11/17/cancer-du-pancreas-la-commission-europeenne-donne-son-feu-vert-a-un-nouveau-traitement_6813042_3234.html)
- WHO
-
- 39 million deaths by 2050: the fight against antibiotic resistance is making progress, but the world must redouble its efforts (https://sante.lefigaro.fr/social/sante-publique/39-millions-de-morts-redoutes-d-ici-2050-la-lutte-contre-la-resistance-aux-antibiotiques-progresse-mais-le-monde-doit-redoubler-d-efforts-selon-l-oms-20261116)
National Healthcare Policy
- Healthcare proposals ahead of the November 29th elections
o Healthcare: the notable absentee from the Sánchez-Feijóo debate. The candidates from the PSOE and PP failed to address key healthcare issues—beyond the doctors’ strike, the hiring of additional professionals, and the occasional inclusion of inaccurate data (https://www.diariomedico.com/medicina/politica/sanidad-gran-ausente-cara-cara-sanchez-feijoo.html)
o The “Frente Amplio” (Broad Front) proposes abolishing the administrative mutual insurance system for civil servants (https://www.consalud.es/politica/frente-amplio-propone-suprimir-muface-isfas-y-mugeju-e-integrar-a-mas-de-218-millones-de-mutualistas-al-sns.html)
o Ending private management, allocating 8% of GDP to healthcare, and safeguarding primary care are the cornerstones of the “Frente Amplio” platform (https://www.consalud.es/politica/fin-de-la-gestion-privada-8-del-pib-para-sanidad-y-blindaje-de-la-atencion-primaria-frente-amplio-presenta-su-programa.html)
- Central Administration
o COVID-19 to be classified as an occupational illness for healthcare workers and caregivers. The Social Security administration is processing a royal decree to this effect, which will also cover staff in penitentiary facilities and law enforcement personnel. Everything points to its approval before the general elections (https://www.elespanol.com/invertia/observatorios/sanidad/20261119/gobierno-mueve-ficha-covid-enfermedad-profesional-sanitarios-cuidadores-definitivamente/1003744463574_0.html)
o The government is increasing the ISFAS healthcare agreement budget by 8.2% to prevent the tender from failing due to a lack of bidders once again. The Council of Ministers has given the green light to “inject” 50 million into the bidding process (https://www.elespanol.com/invertia/observatorios/sanidad/20261118/gobierno-eleva-presupuesto-concierto-sanitario-isfas-evitar-vuelva-quedar-desierto/1003744462307_0.html)
- Regional administrations
o Doctors’ strike in Andalusia in November, organized by the United Doctors’ Union (Sindicato de Médicos Unidos) (https://www.elconfidencial.com/salud/2026-11-19/huelga-medicos-andalucia-fechas-y-detalles-1qrt_4467244/)
o Osakidetza launches its first public employment selection process (OPE) for individuals with intellectual disabilities (https://www.consalud.es/autonomias/pais-vasco/osakidetza-lanza-la-primera-ope-para-personas-con-discapacidad-intelectual-30-plazas-tres-categorias-tecnicas-y-examen-en-lectura-facil.html)
- Infectious Diseases specialty
o The proposal to establish this specialty has been rejected by the National Council of Specialties. Dr. Javier Membrillo, president of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), reported this Wednesday that the mandatory assessment from the National Council of Specialties has rejected the proposal to establish a formal medical specialty in infectious diseases. (https://isanidad.com/395386/creacion-infecciosas-recibe-negativa-consejo-nacional-especialidades-denuncia-seimc/)
- State Public Health Agency
o The Government has approved the statute for the State Public Health Agency. This body, which will operate under the Ministry of Health, will possess its own legal status and the autonomy to manage health emergencies. (https://www.redaccionmedica.com/politica/20261117/el-gobierno-aprueba-el-estatuto-de-la-nueva-agencia-estatal-salud-publica/365566_0.html)
- ISFAS
o The new ISFAS model has drawn interest from four health insurance companies. Both AXA and Mapfre are currently evaluating their potential participation. (https://www.redaccionmedica.com/politica/muface/20261120/el-modelo-muface-atrae-el-interes-de-cuatro-aseguradoras-para-nuevo-concierto-las-fuerzas-armadas/366013_0.html)
Companies
- International
o A Missouri judge approves a $7.25 billion settlement for Bayer (https://www.reuters.com/legal/government/missouri-judge-approves-bayers-725-billion-roundup-settlement-2026-11-20/)
o Johnson & Johnson acquires an ophthalmology-focused biotech company for $3.3 billion (https://www.ft.com/content/450100ba-074c-46a6-b962-89dbef146135?syn-25a6b1a6=1)
o Lilly sets a record with $51 billion in deals since January. The pharmaceutical company—maker of Mounjaro and Zepbound—has announced 16 agreements since the beginning of the year, including acquisitions and strategic alliances, to diversify its portfolio (https://www.expansion.com/empresas/industria/2026/11/18/lilly-bate-record-acuerdos-51-100-millones-enero.html)
- Domestic
o The Consumer Health (self-care) market grows to €9 billion. The industry association calls for regulatory stability and advocates for strengthening the role of pharmacists to promote disease prevention and healthcare sustainability (https://forbes.es/health/1068007/crecimiento-sector-autocuidado-2026/)
o Esteve is set to complete the relocation of its operations to its new industrial plant in China by 2028. The new infrastructure will allow the company to get closer to Asian clients and strengthen its collaboration with international pharmaceutical firms (https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261120/esteve-culminara-en-el-traslado-de-sus-operaciones-su-nueva-planta-industrial-china/366018_0.html)
o HM Hospitales and the Torrelodones City Council are promoting a public-private cooperation model to anticipate disease. The agreement establishes a framework for collaboration between local government and the private healthcare sector, combining local knowledge with proximity to the public (https://www.redaccionmedica.com/empresas/sanidad-privada/20261117/hm-hospitales-el-ayuntamiento-de-torrelodones-impulsan-un-modelo-cooperacion-publico-privada-para-anticiparse-la-enfermedad/365655_0.html)
o Atrys grows by nearly 10%, driven by Latin America and its oncology division (https://www.expansion.com/catalunya/2026/11/16/atrys-crece-10-impulsada-america-latina-division-oncologica.html)
o Germany is set to hit the sales of Almirall, Rovi, and Pharmamar, while providing a safeguard for Grifols (https://www.eleconomista.es/salud-bienestar/noticias/14027765/11/26/alemania-golpeara-las-ventas-de-almirall-rovi-y-pharmamar-mientras-blinda-a-grifols.html)
This post is also available in:


